Cosmos Holdings

Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. It is also involved in the research and development of its business units, and acquisition of pharmaceutical companies. The firm offers over-the-counter drugs, branded and generic medicines, and dietary and vitamin supplements. The company was founded on July 21, 2009 and is headquartered in Chicago, IL.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q2 2024

Earnings data Q1 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. It is also involved in the research and development of its business units, and acquisition of pharmaceutical companies. The firm offers over-the-counter drugs, branded and generic medicines, and dietary and vitamin supplements. The company was founded on July 21, 2009 and is headquartered in Thessaloniki, Greece.

Helbiz

 Nuwellis

Use these tips for buying penny stocks right now The post Buying Penny Stocks as 2022 Ends? 3 Tips and Tricks  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Buying Penny Stocks as 2022 Ends? 3 Tips and Tricks

Cosmos Holdings (NASDAQ: COSM ) stock is ripping higher on Wednesday, currently up more than 20% so far today. At today's high, though, COSM stock was up more than 100%.

Is a Giant Short Squeeze Brewing in Cosmos (COSM) Stock?

Palisade Bio

Check out these tips for trading penny stocks The post Should You Be Buying Penny Stocks? Here's 3 Reasons Why appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Should You Be Buying Penny Stocks? Here's 3 Reasons Why

Siyata Mobile Inc.

Wish

How to trade under $1 penny stocks The post Buying Penny Stocks Under $1? What You Need to Know  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Buying Penny Stocks Under $1? What You Need to Know

CHICAGO, IL / ACCESSWIRE / November 21, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (Nasdaq:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that its Sky Premium Life luxury food supplement brand will be sold on Ronda, the official inflight magazine of the airline company Iberia of BRITISH AIRWAYS group. Ronda is available free of charge to the over 10 million passengers who fly Iberian Airlines annually.

Cosmos Health to Sell its Sky Premium Life Luxury Food Supplement Brand on Iberian Airlines' In-flight Magazine, Ronda.

Ambev

Ardelyx

This is what penny stocks need to succeed in 2022 The post What Do Penny Stocks Need to Succeed in 2022?  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

What Do Penny Stocks Need to Succeed in 2022?

Compugen

GoHealth, Inc.

Volta

Penny stocks under $1 to watch before next week. The post 4 Cheap Penny Stocks To Buy For Under $1 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Cheap Penny Stocks To Buy For Under $1 Right Now

Stock will continue to trade on Nasdaq beyond November 21, 2022 CHICAGO, IL / ACCESSWIRE / November 17, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (NASDAQ:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that on November 10, 2022, Cosmos Holdings received a non-compliance letter from the Nasdaq Stock Market for its failure to maintain a minimum closing bid price of $0.10 per share for ten (10) consecutive business days in accordance with Nasdaq Listing Rule 5810(c)(3)(A)(ii). Pursuant to a prior non-compliance letter from Nasdaq dated July 26, 2022, the Company had until January 23, 2023, to regain compliance by the closing bid price of the Company's common stock being at least $1.00 per share for ten (10) consecutive trading days.

Cosmos Health Requests Appeal from the Nasdaq Stock Market

CHICAGO, IL / ACCESSWIRE / November 15, 2022 / Cosmos Holdings (d/b/a Cosmos Health, Inc. ) ("the Company") (Nasdaq:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today provided a business update and reported financial results for the third quarter and nine months ended September 30, 2022. Third Quarter 2022 Financial Highlights Revenues were $12.0M versus $13.6M in 3Q21.

Cosmos Health Reports Third Quarter 2022 Financial Results

Freight Technologies Inc

Exela Technologies

Are you trading penny stocks with these tips? The post Don't Invest in Penny Stocks Until You've Learned These Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Don't Invest in Penny Stocks Until You've Learned These Tips

Yamana Gold

Trading tips for penny stocks as 2022 comes to an end The post End of Year Penny Stocks Trading Recommendations  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

End of Year Penny Stocks Trading Recommendations

Fast Radius

Opendoor

Use these penny stocks trading strategies The post Advanced Penny Stocks Trading Strategies to Consider  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Advanced Penny Stocks Trading Strategies to Consider

ESSA Pharma

RLX Technology

SINTX Technologies Inc

Use these strategies for making money with penny stocks The post Top Strategies for Making Money With Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Top Strategies for Making Money With Penny Stocks

Black Diamond Therapeutics

IMARA

Local Bounti Corp

Penny stock picks from Insiders in October 2022. The post 4 Penny Stocks To Buy: Insider Picks For October appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Penny Stocks To Buy: Insider Picks For October

Adamis Pharmaceuticals

AnPac Bio-Medical Science Co

Borqs Technologies

Clever Leaves Holdings Inc

Corbus Pharmaceuticals Holdings

Altamira Therapeutics Ltd

Matinas BioPharma Hlds

Nutex Health Inc

Oblong

Penny stocks to watch under $1 right now. The post 10 Top Penny Stocks To Buy For Uner $1 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

10 Top Penny Stocks To Buy For Uner $1 Right Now

Penny stocks to watch under $1 right now. The post Good Penny Stocks To Buy Now?

Good Penny Stocks To Buy Now? 7 Under $1 To Watch This Week

CHICAGO, IL / ACCESSWIRE / October 18, 2022 / Cosmos Holdings (d/b/a Cosmos Health, Inc.) ("Cosmos" or the "Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced the pricing of its "reasonable best efforts" public offering of 62,500,000 shares of common stock (or common stock equivalents), Series A Warrants to purchase 62,500,000 shares of common stock and Series B Warrant to purchase 62,500,000 shares of common stock at a combined price of $0.12 per share and warrant for aggregate gross proceeds of $7.5 million, before deducting placement agent fees and other offering expenses. The offering includes participation from Grigorios Siokas, CEO of Cosmos Holdings, Inc. as well as various Company advisors.

Cosmos Health Announces Pricing of $7.5 Million Upsized Public Offering

Provides Additional Financial Flexibility in Exchange for New Warrants CHICAGO, IL / ACCESSWIRE / October 4, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("Cosmos") (NASDAQ:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that it has entered into an agreement to replace its previously structured warrants with new vanilla warrants. The existing holders of Warrants issued as of February 28, 2022 will purchase an aggregate of 21,238,254 shares of Common Stock.

Cosmos Health Enters into a Warrant Exchange Agreement, Replacing Structured Warrants with Plain-Vanilla Warrants

CHICAGO, IL / ACCESSWIRE / September 22, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("Cosmos") (NASDAQ:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that it has entered into an agreement with Virax Biolabs (VRAX), to become the distributor of Monkeypox Virus Real-Time PCR Detection Kits. Cosmos will have exclusive distribution rights for Greece and Cyprus, with the opportunity to distribute the test kits across Europe on a non-exclusive basis.

Cosmos Health Signs an Agreement with Virax Biolabs to Distribute Monkeypox Virus Real-Time PCR Detections Kits in Europe

Virax Biolabs Group Ltd

Exclusive distribution agreement signed with Cosmos Holdings Inc. (Nasdaq: COSM), providing for exclusive distribution rights in Greece and Cyrus with the opportunity for Cosmos to distribute across Europe on a non-exclusive basis. LONDON , Sept.

Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

CHICAGO, IL / ACCESSWIRE / September 15, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (Nasdaq:COSM) , is a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that the Company's proprietary line of nutraceuticals, Sky Premium Life, has entered into an exclusive agreement with Mediprovita GbR. Mediprovita will begin selling its Sky Premium Life ("SPL") products in Germany and Austria beginning in the Fourth Quarter.

Cosmos Health to Launch Sky Premium Life Nutritional Supplement Products in Germany and Austria via Amazon and Ebay

CHICAGO, IL / ACCESSWIRE / August 25, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (NASDAQ:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that the Company's subsidiary, SkyPharm S.A., a pharmaceutical wholesaler and distributor, officially launched its first Sky Premium Life ("SPL") products on Amazon in the United States.

Cosmos Health Launches First Sky Premium Life Nutritional Supplement Products on Amazon in the United States

CHICAGO, IL / ACCESSWIRE / August 22, 2022 / Cosmos Health, Inc. ("the Company") (NASDAQ:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices,today provided a business update and reported financial results for the second quarter and six months ended June 30, 2022. Greg Siokas, Chief Executive Officer of Cosmos Health, stated, "We increased our profitability for the first half of 2022 due to the increase of gross profit margin to 14.2% from 11.5% for the respective period of 2021.

Cosmos Health Reports 202.42 % Increase in Adjusted EBITDA and Positive Operating Income for the First Half of 2022

CHICAGO, IL / ACCESSWIRE / July 29, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) announced today that it is changing the name of the Company to Cosmos Healthto better reflect the Company's evolution into an innovative global healthcare group with a focus on improving people's lives. The enhancement with cutting edge technlogies for the development of its pharmaceutical and nutraceutical products, through its vertical integrated ecosystem, will enable Cosmos Health to implement its goal of becoming a global healthcare group, committed to human health needs.

Cosmos Holdings Announces Name Change to Cosmos Health, Reflecting Company's Evolution into an Innovative Global Healthcare Group, Driven by One Purpose: Improving People's Lives

Aphria

CHICAGO, IL / ACCESSWIRE / July 22 , 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, today announced that it has appointed finance veteran Dr. Manfred Ziegler to the Company's Advisory Board. Dr. Ziegler brings over 30 years of executive management, financial, and operational experience, as well as extensive expertise in mergers and acquisitions, with a particular focus on high-growth public and private companies.

Cosmos Holdings Appoints Dr. Manfred Ziegler to its Advisory Board

News for Cosmos Holdings Stock (COSM)